Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 1088400152

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    202

Stocks News & Analysis

stocks

Vote in favour of merger for undervalued ASX share

We recommend shareholders vote in favor of its proposed merger.
stocks

Are investors missing the boat on this future ASX leader?

The market is underestimating the clear path to profitability.
stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,557.4011.70-0.14%
CAC 407,716.5481.801.07%
DAX 4020,874.18218.791.06%
Dow JONES (US)43,153.1368.42-0.16%
FTSE 1008,508.03116.131.38%
HKSE19,584.0661.170.31%
NASDAQ19,338.29172.95-0.89%
Nikkei 22538,451.46121.14-0.31%
NZX 50 Index13,130.43129.761.00%
S&P 5005,937.3412.57-0.21%
S&P/ASX 2008,310.4016.60-0.20%
SSE Composite Index3,241.825.790.18%

Market Movers